Saturday 17 October 2026 Export STE’s income statement to Excel — free account

STERIS plc

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%

Follow STE

Alert me

Market cap: $21.9B
P/E: 27.1×
Fwd P/E: 23.6×
Dividend yield: 1.16%
F-score: 9/9
Altman Z: 5.10
Beneish M: −2.68
Dividend safety: 86/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 9.83

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	3	—	—	—	1	—	—	3	—	1	—	—

Insider Ownership 0.44%

Capital & Financial Ratios $m

Market Cap 21,870.00

Revenue 6,037.50

Net Income 808.10

Free Cash Flow 936.00

Net Debt 1,411.30

Current Ratio 1.91

Debt/Equity 0.26

P/E ratio 27.12

Fwd P/E 23.60

P/S ratio 3.60

P/B ratio 3.01

Past 5Y EPS Growth 11.36%

This Y EPS Growth 10.19%

Next Y EPS Growth 9.30%

Next Y revenue growth 7.35%

Next 5Y EPS Growth 9.81%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 3.67%

10-year low 10-year high

P/S against its own 10 years 29.75%

10-year low 10-year high

P/B against its own 10 years 33.39%

10-year low 10-year high

EV/Sales against its own 10 years 27.53%

10-year low 10-year high

EV/FCF against its own 10 years 5.49%

10-year low 10-year high

Dividends

Payout Ratio 0.32

Annual Dividend Rate 2.58

Annual Dividend Yield 1.16%

	total	individual payouts
2029	Powerpack
2028	Powerpack
2027	Powerpack
2026	2.43	0.63 0.63 0.69
2025	2.40	0.57 0.57 0.63 0.63
2024	2.18	0.52 0.52 0.57 0.57
2023	1.98	0.47 0.47 0.52 0.52
2022	1.80	0.43 0.43 0.47 0.47
2021	1.66	0.40 0.40 0.43 0.43
2020	1.54	0.37 0.37 0.40 0.40
2019	1.42	0.34 0.34 0.37 0.37
2018	1.30	0.31 0.31 0.34 0.34
2017	1.18	0.28 0.28 0.31 0.31
2016	1.06	0.25 0.25 0.28 0.28

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2024	2025	2026	Q'26
Cash	207	172	440	482
Receivables	1,008	1,044	1,093	1,013
Inventory	675	581	632	712
Other	805	—	—	—
	2,869	2,001	2,395	2,446

	2024	2025	2026	Q'26
Payables	252	281	339	344
ST’ Debt	86	125	119	243
Other	64	616	687	696
	931	1,022	1,145	1,283

Compound Annual Growth %

	10y	5y	3y
Sales	10.24%	13.82%	9.38%
Cash Flow	18.07%	14.23%	21.01%
Earnings	21.59%	14.51%	94.07%
Book Value	9.00%	13.09%	5.74%

Revenue $m

	Jun	Sep	Dec	Mar	Year
’26	1,493	—	—	—	—
’26	1,391	1,460	1,496	1,588	5,936
’25	1,280	1,329	1,371	1,481	5,460
’24	1,183	1,238	1,298	1,419	5,139
’23	1,156	1,201	1,216	963	4,536
’22	968	1,197	1,209	849	4,223
’21	669	756	809	874	3,108

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jun	Sep	Dec	Mar	Year
’26	367	—	—	—	—
’26	420	288	298	335	1,341
’25	304	251	333	261	1,148
’24	281	146	291	255	973
’23	232	104	206	216	757
’22	97	171	244	172	685
’21	134	162	206	188	690

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jun	Sep	Dec	Mar	Year
’26	280	—	—	—	—
’26	327	201	210	245	983
’25	196	149	244	199	787
’24	215	70	172	163	620
’23	117	21	125	147	410
’22	41	95	165	99	399
’21	67	118	152	113	451

Fiscal quarters ending in the months shown.

EPS $

	Jun	Sep	Dec	Mar	Year
’26	2.04	—	—	—	—
’26	1.79	1.94	1.96	2.24	7.93
’25	1.46	1.51	1.75	1.48	6.20
’24	1.25	1.16	1.42	(0.01)	3.81
’23	1.10	(3.15)	1.24	1.88	1.07
’22	(0.24)	0.69	1.42	0.52	2.48
’21	1.03	1.23	1.33	1.02	4.63

Fiscal quarters ending in the months shown.

Group	Line	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027e
Price, $
Price, $	Low	65.27	82.88	100.91	105.69	170.36	159.21	173.21	197.82	200.98	195.14	Analyst estimates 2027–2029 Powerpack
	High	93.39	121.67	156.66	196.80	245.82	255.93	254.00	248.24	268.60	269.44
People
People	Employees	12,000	12,000	12,000	13,000	13,000	16,422	17,100	18,179	17,787	17,937
	Revenue/emp, $m	0.22	0.22	0.23	0.23	0.24	0.26	0.27	0.28	0.31	0.33
Income, $m
Income, $m	Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139	5,460	5,936
	Gross margin, %	39.28	41.71	42.23	43.55	43.22	44.59	43.66	43.16	44.01	44.25
	EBT	185	355	369	499	518	367	680	703	796	1,047
	EBT margin, %	7.07	13.55	13.26	16.46	16.65	8.69	15.00	13.68	14.58	17.64
	Net income	111	292	305	408	397	243	106	380	616	785
	Depreciation	246	178	226	197	219	620	560	570	476	487
Per share, $
Per share, $	Revenue	30.57	30.81	32.90	35.75	36.47	43.30	45.50	52.01	55.37	60.45
	Earnings	1.29	3.42	3.59	4.81	4.66	2.50	1.07	3.83	6.24	7.97
	Cash flow	4.96	5.38	6.38	6.97	8.09	7.02	7.59	9.85	11.64	13.66
	Capex	(1.97)	(1.92)	(2.18)	(2.48)	(2.80)	(2.93)	(3.48)	(3.57)	(3.66)	(3.65)
	Free cash flow	3.00	3.46	4.20	4.48	5.29	4.09	4.11	6.28	7.98	10.01
	Book value	32.88	37.84	37.67	40.32	45.67	67.10	61.05	63.92	67.10	73.29
	Shares, m	85	85	85	85	85	98	100	99	99	98
Valuation, ×
Valuation, ×	P/E	54.27	26.54	35.30	29.10	41.05	99.91	175.49	57.71	36.38	27.78
	P/S	2.27	2.95	3.87	3.92	5.22	5.58	4.20	4.25	4.09	3.66
	P/B	2.11	2.41	3.38	3.47	4.17	3.60	3.13	3.46	3.38	3.02
	EV/Sales	2.73	3.38	4.22	4.20	5.69	6.23	4.84	4.83	4.44	3.91
	EV/FCF	27.86	30.09	33.04	33.45	39.21	65.97	53.57	40.03	30.77	23.61
Cash, $m
Cash, $m	Operating cash flow	424	458	540	591	690	685	757	973	1,148	1,341
	Capex	(168)	(163)	(184)	(210)	(239)	(286)	(347)	(353)	(361)	(358)
	Free cash flow	256	294	355	380	451	399	410	620	787	983
Balance, $m
Balance, $m	Working capital	636	591	589	720	634	957	1,150	1,938	979	1,250
	Total debt	1,478	1,316	1,183	1,171	1,674	3,088	3,079	3,206	2,044	1,932
	Net debt	1,195	1,114	963	851	1,453	2,740	2,870	2,999	1,872	1,492
	Shareholders’ equity	2,810	3,217	3,186	3,418	3,891	6,545	6,087	6,315	6,616	7,197
Returns, %
Returns, %	ROA	2.14	5.75	5.91	7.75	6.61	2.71	0.96	3.46	5.80	7.49
	ROIC	3.53	5.77	6.19	7.86	6.41	3.22	5.52	5.61	6.38	7.92
	ROE	3.76	9.65	9.49	12.35	10.87	4.67	1.69	6.10	9.51	11.33

Negative figures in brackets.

All 10 years →

Fiscal years to Mar 2026 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
DXCM DexCom, Inc.	$33.1B	33.2×	29.8×	+13.08% (above 0%: growing)	+41.30% (above 0%: growing)	−11.68% (below 0%: shrinking)	63.44%	24.33%	Compare
GEHC GE HealthCare Technologies Inc.	$31.8B	16.0×	14.4×	+5.75% (above 0%: growing)	+16.98% (above 0%: growing)	+750.00% (above 0%: growing)	41.17%	13.96%	Compare
PHG Koninklijke Philips N.V.	$24.9B	18.8×	11.2×	+2.94% (above 0%: growing)	+56.67% (above 0%: growing)	+49.74% (above 0%: growing)	49.31%	13.99%	Compare
STE STERIS plc	$21.9B	27.1×	23.6×	+7.30% (above 0%: growing)	+13.89% (above 0%: growing)	−14.36% (below 0%: shrinking)	45.84%	19.15%
ZBH Zimmer Biomet Holdings, Inc.	$18.0B	23.0×	17.7×	+4.80% (above 0%: growing)	+33.77% (above 0%: growing)	+13.05% (above 0%: growing)	70.81%	14.98%	Compare
PEN Penumbra, Inc.	$12.7B	78.4×	63.5×	+14.90% (above 0%: growing)	−24.79% (below 0%: shrinking)	+10.81% (above 0%: growing)	67.93%	10.52%	Compare
SNN Smith & Nephew SNATS, Inc.	$12.2B	35.4×	18.6×	+7.99% (above 0%: growing)	−14.23% (below 0%: shrinking)	+293.94% (above 0%: growing)	69.42%	0.00%	Compare
GMED Globus Medical, Inc.	$10.6B	19.3×	20.3×	+5.94% (above 0%: growing)	−25.33% (below 0%: shrinking)	+571.30% (above 0%: growing)	69.42%	23.10%	Compare
BIO.B Bio-Rad Laboratories, Inc.	$10.3B	43.7×	—	−0.09% (below 0%: shrinking)	+19.02% (above 0%: growing)	−6.06% (below 0%: shrinking)	53.12%	11.15%	Compare
Median of peers	$15.3B	28.1×	18.6×	+5.85%	+18.00%	+31.40%	65.68%	13.97%

All 149 Medical Devices stocks →

STERIS plc (STE) key facts

Strength: STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
Strength: Net income was $785.1 million, or $7.97 per share (basic), a net margin of 13.2%.
STERIS plc (STE) is a Medical Devices company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, STE traded at $222.66, a market capitalization of $21.9 billion.
At that price the stock trades at 27.1× trailing-twelve-month earnings and 3.6× sales; its P/E is higher than 4% of its own readings over the past ten years.
STERIS plc pays an annual dividend of $2.58 per share, a yield of 1.16%, with a payout ratio of 31.5%.
Return on equity was 11.3% and debt-to-equity 0.26.
Its Piotroski F-score is 9 out of 9 and its Altman Z-score is 5.10 (safe zone) for fiscal 2026.